EU Health Commissioner Olivér Várhelyi visits MyoPax at the Bayer Co.Lab

This week, the EU Health Commissioner, Olivér Várhelyi, visited the Bayer Co.Lab in Berlin, one of our MyoPax homes. Joined by Stefan Oelrich (Bayer President Pharmaceuticals), the visit enabled a discussion on the systemic challenges EU biotech startups face. The exchange focused on the complexity of securing financing, and the novel infrastructure achievements in Berlin that enable the translation of scientific discoveries into clinical trials. We are hopeful that clearing key bottlenecks will foster and build successful EU biomedical innovations.

Thank you to Olivér Várhelyi, Stefan Oelrich, and the brilliant Bayer Co.Lab team for this vital dialogue on the future of translational medicine in Europe!